GGrantIndex
← Leaderboards

Lisa A Lesniewski

Va Salt Lake City Healthcare System

$4,670,799
Attributed
$5,567,157
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $905.7K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,567,157 · 7
VA$0 · 2

By mechanism

R01$4,406,281 · 3
R21$741,789 · 2
K01$375,111 · 1
F32$43,976 · 1
I01$0 · 2

Top collaborators

Others in their field

Top investigators on “Inflammation

Research focus

InflammationFunctional DisorderTissuesEndotheliumBlood VesselsAgingElderlyMediatingOxidative StressPhenotypeCardiovascular DiseasesDietAdultPublic Health RelevanceAtherosclerosisCellsEndothelial CellsNitric OxideConsumptionFatty Acid Glycerol EstersBiological AvailabilityMiddle AgeImpairmentFeeding

Grant awards (29)

Integrative Mechanisms of Vascular Aging$450,486
R01 · FY2025 · AG
Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation$436,920
R01 · FY2025 · AG · contact PI
Integrative Mechanisms of Vascular Aging$459,678
R01 · FY2024 · AG
Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation$445,838
R01 · FY2024 · AG · contact PI
Integrative Mechanisms of Vascular Aging$472,803
R01 · FY2023 · AG
Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation$432,850
R01 · FY2023 · AG · contact PI
Role of ARF6 in atherosclerotic burden and severity$0
I01 · FY2023 · VA · contact PI
Role of ARF6 in atherosclerotic burden and severity$0
I01 · FY2022 · VA · contact PI
Role of ARF6 in atherosclerotic burden and severity$0
I01 · FY2021 · VA · contact PI
Mechanisms of augmented atherosclerotic progression with aging$312,625
R01 · FY2020 · AG · contact PI
Role of ARF6 in atherosclerotic burden and severity$0
I01 · FY2020 · VA · contact PI
Mechanisms of augmented atherosclerotic progression with aging$312,625
R01 · FY2019 · AG · contact PI
Mechanisms of augmented atherosclerotic progression with aging$311,087
R01 · FY2018 · AG · contact PI
Metabolic implications of adipose arterial function: Role of Robo4 and AMPK$0
I01 · FY2018 · VA · contact PI
Mechanisms of augmented atherosclerotic progression with aging$310,319
R01 · FY2017 · AG · contact PI
Age-associated Cognitive Impairment: Impact of Atherosclerosis$151,500
R01 · FY2017 · AG · contact PI
Metabolic implications of adipose arterial function: Role of Robo4 and AMPK$0
I01 · FY2017 · VA · contact PI
Mechanisms of augmented atherosclerotic progression with aging$309,550
R01 · FY2016 · AG · contact PI
Metabolic implications of adipose arterial function: Role of Robo4 and AMPK$0
I01 · FY2016 · VA · contact PI
Metabolic implications of adipose arterial function: Role of Robo4 and AMPK$0
I01 · FY2015 · VA · contact PI
Reversing Arterial Aging via mTOR Inhibition: AMPK Activation as a Rapalog$223,500
R21 · FY2014 · AG
Reversing Arterial Aging via mTOR Inhibition: AMPK Activation as a Rapalog$186,250
R21 · FY2013 · AG
Aging, Western Diet and Endothelial Dysfunction: Role of NFkB and JNK Activation$176,751
R21 · FY2011 · AG · contact PI
Aging, Western Diet and Physiological Dysfunction: Exercise and Inflammation$125,037
K01 · FY2011 · AG · contact PI
Aging, Western Diet and Endothelial Dysfunction: Role of NFkB and JNK Activation$135,350
R21 · FY2010 · AG · contact PI
Aging, Western Diet and Physiological Dysfunction: Exercise and Inflammation$125,037
K01 · FY2010 · AG · contact PI
Aging, Western Diet and Endothelial Dysfunction: Role of NFkB and JNK Activation$19,938
R21 · FY2010 · AG · contact PI
Aging, Western Diet and Physiological Dysfunction: Exercise and Inflammation$125,037
K01 · FY2009 · AG · contact PI
Role of CAP in In Vivo Insulin Action$43,976
F32 · FY2005 · DK